For today’s episode, I interviewed Miruna Sasu about Real World Evidence and how that is changing the world of drug development and clinical trials.

Who’s The Guest? Miruna Sasu, PhD, MBA is the President and CEO of COTA. She has more than 20 years of experience at leading life science organizations such as Johnson & Johnson and Bristol-Myers Squibb. She also has both a Ph.D. in biology and statistics and a master’s in business administration.

Miruna is an accomplished executive with a track record of success when it comes to driving broad-based digital innovation. She brings her deep experience in the utilization and scaling of emerging innovations to advance drug portfolios.

Episode Sponsored By Gilead

Episode Resources

• Connect with Arundhati Parmar
• aparmar@medcitynews.com
• https://twitter.com/aparmarbb?lang=en
• https://medcitynews.com/
• Connect with Miruna Sasu
• https://cotahealthcare.com/
• ​​https://www.linkedin.com/in/miruna-sasu-7198a113  

Review, Subscribe and Share If you like what you hear please leave a review by clicking here

Make sure you’re subscribed to the podcast so you get the latest episodes.

• Click here to subscribe with Apple Podcasts
• Click here to subscribe with Spotify
• Click here to subscribe with Podbean
• Click here to subscribe with RSS